This Article Full Text Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Boldt, J. Articles by Suttner, S. Search for Related Content PubMed PubMed Citation Articles by Boldt, J. Articles by Suttner, S. Related Collections Critical Care Trauma Blood

---

GENERAL ARTICLES

The Value of an Albumin-Based Intravascular Volume Replacement Strategy in Elderly Patients Undergoing Major Abdominal Surgery

From the Clinic of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Germany.

Address correspondence and reprint requests to Joachim Boldt, MD, PhD, Clinic of Anesthesiology and Intensive Care Medicine, Klinikum der Stadt Ludwigshafen, Bremserstr 79, D-67063 Ludwigshafen, Germany. Address e-mail to BoldtJ{at}gmx.net.

The value of human albumin (HA) for treating hypovolemia is controversial. Less expensive alternatives such as hydroxyethyl starch (HES) are sometimes refused because of unwanted side effects. We prospectively randomized 50 patients older than 70 years old undergoing major abdominal surgery to receive either 5% HA (n = 25) or a third generation HES preparation (6% HES 130/0.4; n = 25) when mean arterial blood pressure was <60 mm Hg and central venous pressure was <10 mm Hg. Hemodynamics, inflammation (interleukin-6), endothelial activation-integrity (adhesion molecules), coagulation (thrombelastography), and renal function (including kidney-specific proteins) were monitored after the induction of anesthesia, after surgery, 5 h in the intensive care unit, and on the first postoperative day. HA patients received 3960 ± 590 mL of HA and 5070 ± 1030 mL of Ringer’s lactate solution, and HES patients received 3500 ± 530 mL of HES and 4550 ± 880 mL of Ringer’s lactate solution. Total protein remained normal only in the HA-treated patients. No significant differences (P > 0.1) between the groups were seen with regard to hemodynamics, coagulation, and kidney function. Plasma levels of interleukin-6 and soluble adhesion molecules were significantly (P < 0.05) higher in the HA- than in the HES-treated patients. We conclude that HA in elderly patients undergoing major abdominal surgery can easily be replaced by a modern HES preparation. Because of the decreased inflammatory response and endothelial activation-injury, HES 130/0.4 seems to be the more appropriate fluid strategy for these patients.

This article has been cited by other articles:

				A. A. Schramko, R. T. Suojaranta-Ylinen, A. H. Kuitunen, S. I. Kukkonen, and T. T. Niemi Rapidly Degradable Hydroxyethyl Starch Solutions Impair Blood Coagulation After Cardiac Surgery: A Prospective Randomized Trial Anesth. Analg., January 1, 2009; 108(1): 30 - 36. [Abstract] [Full Text] [PDF]